Good embolization response for colorectal liver metastases with hypervascularity

Area of Science:

• Interventional Radiology
• Oncology
• Medical Imaging

Background:

• Colorectal liver metastases are a common clinical challenge.
• Transcatheter arterial embolization (TAE) is a treatment option for unresectable liver metastases.
• Predicting treatment response is crucial for patient management.

Purpose of the Study:

• To determine if tumor hypervascularity on diagnostic imaging predicts response to TAE in colorectal liver metastases.
• To correlate imaging findings with treatment outcomes.

Main Methods:

• 45 patients with colorectal liver metastases treated with TAE were retrospectively analyzed.
• Tumor vascularity was assessed using contrast-enhanced computed tomography and angiography.
• Patients were grouped based on vascularity (hypervascular vs. hypovascular) and angiography phase.
• Tumor response, serum carcinoembryonic antigen (CEA) levels, and survival rates were compared between groups.

Main Results:

• Partial response to TAE was observed only in patients with hypervascular tumors (Group IA).
• Patients with hypervascular tumors (Groups IA and IB) showed significantly lower increases in serum CEA compared to hypovascular groups (IIB and IIC).
• Survival rates were slightly higher in the hypervascular group (IA) but not statistically significant.

Conclusions:

• Tumor hypervascularity on diagnostic imaging is a key predictor of successful transcatheter arterial embolization for colorectal liver metastases.
• TAE is most effective when applied to hypervascular liver metastases.
• Imaging-based assessment of tumor vascularity can guide treatment decisions for colorectal liver metastases.